Exchange: OTC·Updated 03:58 PM EDT

ALPMY ASTELLAS PHARMA/ADR

$14.32
$0.12
(0.83%)
Today
EarningsOct 29
Mkt Cap$25.68B
Vol92,997.00

About ALPMY

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
54

Neutral Sentiment

How do you feel about ALPMY?

Advertisement|Remove ads.